Senti Biosciences Files 8-K on Financials and Operations

Ticker: SNTI · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1854270

Sentiment: neutral

Topics: financial-condition, operations, disclosure

TL;DR

Senti Bio dropped an 8-K detailing financials and operations - check it out!

AI Summary

Senti Biosciences, Inc. filed an 8-K on April 28, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures, other events, and financial statements and exhibits. The company, previously known as Dynamics Special Purpose Corp., is incorporated in Delaware and based in South San Francisco, California.

Why It Matters

This 8-K filing provides crucial updates on Senti Biosciences' financial health and operational status, which are important for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant corporate updates, including financial results and material events, which could impact a company's stock price.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details are within the attached documents.

When was Senti Biosciences, Inc. previously known by another name?

Senti Biosciences, Inc. was formerly known as Dynamics Special Purpose Corp., with a name change date of March 31, 2021.

What is the primary business of Senti Biosciences, Inc. according to the SIC code?

The Standard Industrial Classification (SIC) code is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.

Where is Senti Biosciences, Inc. headquartered?

The company's business address is located at 2 Corporate Drive, First Floor, South San Francisco, CA 94080.

What is the SEC file number for Senti Biosciences, Inc.?

The SEC file number for Senti Biosciences, Inc. is 001-40440.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Senti Biosciences, Inc. (SNTI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing